- Report
- May 2023
- 169 Pages
Global
From €1829EUR$1,880USD£1,567GBP
€2287EUR$2,350USD£1,959GBP
- Report
- January 2024
- 200 Pages
Global
From €4038EUR$4,150USD£3,459GBP
- Report
- February 2021
- 360 Pages
United States
From €2335EUR$2,400USD£2,000GBP
- Report
- February 2019
- 105 Pages
Global
From €1255EUR$1,290USD£1,075GBP
- Drug Pipelines
- June 2019
- 579 Pages
Global
€21406EUR$22,000USD£18,337GBP
- Report
- June 2019
- 15 Pages
Global
€9730EUR$10,000USD£8,335GBP
- Report
- June 2019
- 15 Pages
Global
€9730EUR$10,000USD£8,335GBP
- Report
- June 2019
- 14 Pages
Global
€9730EUR$10,000USD£8,335GBP
- Report
- February 2021
- 254 Pages
Global
From €10698EUR$10,995USD£9,164GBP
- Report
- January 2019
- 717 Pages
Global
From €21406EUR$22,000USD£18,337GBP
- Report
- April 2021
- 64 Pages
Global
€21406EUR$22,000USD£18,337GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €486EUR$500USD£417GBP
- Report
- January 2019
- 35 Pages
Global
From €973EUR$1,000USD£834GBP
- Report
- June 2019
- 16 Pages
Global
€9730EUR$10,000USD£8,335GBP
- Report
- January 2024
- 86 Pages
Global
From €3500EUR$3,853USD£3,103GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$3,853USD£3,103GBP
- Report
- November 2023
- 35 Pages
Global
From €5663EUR$5,820USD£4,851GBP
Atripla is a combination antiretroviral medication used to treat HIV/AIDS. It is a fixed-dose combination of three drugs: efavirenz, emtricitabine, and tenofovir disoproxil fumarate. It is taken orally once a day and is used to reduce the amount of HIV in the body, allowing the immune system to recover and preventing further damage. Atripla is one of the most commonly prescribed HIV/AIDS drugs in the United States and is used by millions of people worldwide.
Atripla is manufactured by Bristol-Myers Squibb and Gilead Sciences. Other companies that produce HIV/AIDS drugs include GlaxoSmithKline, Merck, and Pfizer. Show Less Read more
